Cargando…
Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel
BACKGROUND: RNA interference (RNAi) is a powerful approach in functional genomics to selectively silence messenger mRNA (mRNA) expression and can be employed to rapidly develop potential novel drugs against a complex disease like cancer. However, naked siRNA being anionic is unable to cross the anio...
Autores principales: | Stanislaus, Anthony, Bakhtiar, Athirah, Salleh, Diyana, Tiash, Snigdha, Fatemian, Tahereh, Hossain, Sharif, Akaike, Toshihiro, Chowdhury, Ezharul Hoque |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407783/ https://www.ncbi.nlm.nih.gov/pubmed/22709569 http://dx.doi.org/10.1186/1475-2867-12-30 |
Ejemplares similares
-
Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs
por: Fatemian, Tahereh, et al.
Publicado: (2018) -
PH-responsive strontium nanoparticles for targeted gene therapy against mammary carcinoma cells
por: Bakhtiar, Athirah, et al.
Publicado: (2021) -
Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor
por: Tiash, Snigdha, et al.
Publicado: (2017) -
Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model
por: Fatemian, Tahereh, et al.
Publicado: (2019) -
siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2018)